Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $135
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $120 to $135.
6 Analysts Have This to Say About Zimmer Biomet Holdings
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…
RBC Capital Maintains Sector Perform on Zimmer Biomet Holdings, Lowers Price Target to $125
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Sector Perform and lowers the price target from $128 to $125.
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $116
Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $119 to $116.
Masimo’s (MASI) Q2 Earnings Surpass Estimates, Margins Down
Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.
NeuroOne Medical Shares Fall After EEG Electrode Regulatory Update
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) has submitted a special 510(k) to the FDA for its sEEG electrode to extend the duration…
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
Zimmer Biomet Holdings Inc’s (NYSE:ZBH) Q2 sales increased by 1% Y/Y to $1.78 billion (up 6% on a constant currency basis),…
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Stifel Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $120
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $140 to $120.